High Cks1 expression in transgenic and carcinogeninitiated mammary tumors is not always accompanied by reduction in p27Kip1

International Journal of Oncology

Volumn 34, Issue 5, 2009, Pages 1425-1431

  Westbrook, Louise ^a   Ramanathan, Harish N ^a   Isayeva, Tatyana ^b   Mittal, Anshu Roy ^a   Qu, Zhican ^a   Johnson, Michael D ^c   Kern, Francis G ^a   Ponnazhagan, Selvarangan ^b   Grubbs, Clinton J ^b   Thottassery, Jaideep V ^a,b  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cks1; Estrogen; Faslodex; Mammary tumors; Myc; p27Kip1; Polyoma middle T; Skp2

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN KINASE SUBUNIT 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; MYC PROTEIN; ONCOPROTEIN; PROTEIN CKS1; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; COLONY FORMATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; NONHUMAN; ONCOGENE C MYC; PLASMID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RAT; TRANSGENE; UBIQUITINATION; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOGENS; CARCINOMA; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; METHYLNITROSOUREA; MICE; MICE, TRANSGENIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 67649448827     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000271     Document Type: Article

References (47)

1. Slotky M, Shapira M, Ben-Izhak O, et al: The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res 7: R737-R744, 2005.
2. Lan Y, Zhang Y, Wang J, et al: Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer 123: 543-551, 2008.
3. Inui N, Kitagawa K, Miwa S, et al: High expression of Cks1 in human non-small cell lung carcinomas. Biochem Biophys Res Commun 303: 978-984, 2003.
4. Shapira M, Ben-Izhak O, Linn S, et al: The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 103: 1336-1346, 2005.
5. Pagano M, Tam SW, Theodoras AM, et al: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685, 1995.
6. Carrano AC, Eytan E, Hershko A and Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193-199, 1999.
7. Carrano AC and Pagano M: Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol 153: 1381-1390, 2001.
8. Ganoth D, Bornstein G, Ko TK, et al: The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 3: 321-324, 2001.
9. Spruck C, Strohmaier H, Watson M, et al: A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 7: 639-650, 2001.
10. Fero ML, Rivkin M, Tasch M, et al: A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85: 733-744, 1996.
11. Fero ML, Randel E, Gurley KE, et al: The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396: 177-180, 1998.
12. Catzavelos C, Bhattacharya N, Ung YC, et al: Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med 3: 227-230, 1997.
13. Porter PL, Malone KE, Heagerty PJ, et al: Expression of cellcycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225, 1997.
14. Tan P, Cady B, Wanner M, et al: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res 57: 1259-1263, 1997.
15. Fredersdorf S, Burns J, Milne AM, et al: High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94: 6380-6385, 1997.
16. Barnes DM and Gillett CE: Cyclin D1 in breast cancer. Breast Cancer Res Treat 52: 1-15, 1998.
17. Qiu TH, Chandramouli GV, Hunter KW, et al: Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT- transgenic mice: correlation to human disease. Cancer Res 64: 5973-5981, 2004.
18. Jamerson MH, Johnson MD and Dickson RB: Of mice and Myc: c-Myc and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 9: 27-37, 2004.
19. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
20. Guy CT, Muthuswamy SK, Cardiff RD, et al: Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 8: 23-32, 1994.
21. Webster MA, Hutchinson JN, Rauh MJ, et al: Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol Cell Biol 18: 2344-2359, 1998.
22. Maglione JE, Moghanaki D, Young LJ, et al: Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res 61: 8298-8305, 2001.
23. Dabrosin C, Palmer K, Muller WJ and Gauldie J: Estradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor explants. Breast Cancer Res Treat 78: 1-6, 2003.
24. Hulit J, Lee RJ, Russell RG and Pestell RG: ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1. Biochem Pharmacol 64: 827-836, 2002.
25. Bloom J and Pagano M: Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 13: 41-47, 2003.
26. Westbrook L, Manuvakhova M, Kern FG, et al: Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells. Cancer Res 67: 11393-11401, 2007.
27. Hayles J, Beach D, Durkacz B and Nurse P: The fission yeast cell cycle control gene cdc2: isolation of a sequence suc1 that suppresses cdc2 mutant function. Mol Gen Genet 202: 291-293, 1986.
28. Hadwiger JA, Wittenberg C, Mendenhall MD and Reed SI: The Saccharomyces cerevisiae CKS1 gene, a homolog of the Schizosaccharomyces pombe suc1+ gene, encodes a subunit of the Cdc28 protein kinase complex. Mol Cell Biol 9: 2034-2041, 1989.
29. Brizuela L, Draetta G and Beach D: p13suc1 acts in the fission yeast cell division cycle as a component of the p34cdc2 protein kinase. EMBO J 6: 3507-3514, 1987.
30. Neve RM, Sutterluty H, Pullen N, et al: Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Oncogene 19: 1647-1656, 2000.
31. Slingerland J and Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183: 10-17, 2000.
32. Okamura M, Unami A, Moto M, et al: The possible mechanism of enhanced carcinogenesis induced by genotoxic carcinogens in rasH2 mice. Cancer Lett 245: 321-330, 2007.
33. Cheng M, Olivier P, Diehl JA, et al: The p21(Cip1) and p27(Kip1) CDK inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583, 1999.
34. Patra D, Wang SX, Kumagai A and Dunphy WG: The xenopus Suc1/Cks protein promotes the phosphorylation of G(2)/M regulators. J Biol Chem 274: 36839-36842, 1999.
35. Reynard GJ, Reynolds W, Verma R and Deshaies RJ: Cks1 is required for G(1) cyclin-cyclin-dependent kinase activity in budding yeast. Mol Cell Biol 20: 5858-5864, 2000.
36. Egan EA and Solomon MJ: Cyclin-stimulated binding of Cks proteins to cyclin-dependent kinases. Mol Cell Biol 18: 3659-3667, 1998.
37. Patra D and Dunphy WG: Xe-p9, a Xenopus Suc1/Cks protein, is essential for the Cdc2-dependent phosphorylation of the anaphase-promoting complex at mitosis. Genes Dev 12: 2549-2559, 1998.
38. Patra D and Dunphy WG: Xe-p9, a Xenopus Suc1/Cks homolog, has multiple essential roles in cell cycle control. Genes Dev 10: 1503-1515, 1996.
39. Morris MC, Kaiser P, Rudyak S, et al: Cks1-dependent proteasome recruitment and activation of CDC20 transcription in budding yeast. Nature 424: 1009-1013, 2003.
40. Tedesco D, Lukas J and Reed SI: The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev 16: 2946-2957, 2002.
41. Wang W, Ungermannova D, Jin J, et al: Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling. Oncogene 23: 1064-1075, 2004.
42. Foster JS, Fernando RI, Ishida N, et al: Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway. J Biol Chem 278: 41355-41366, 2003.
43. Signoretti S, Di Marcotullio L, Richardson A, et al: Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest 110: 633-641, 2002.
44. Boehm M, Yoshimoto T, Crook MF, et al: A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J 21: 3390-3401, 2002.
45. Viglietto G, Motti ML, Bruni P, et al: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/ Akt-mediated phosphorylation in breast cancer. Nat Med 8: 1136-1144, 2002.
46. Grana X, Garriga J and Mayol X: Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17: 3365-3383, 1998.
47. Carroll JS, Prall OW, Musgrove EA and Sutherland RL: A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence. J Biol Chem 275: 38221-38229, 2000.